Q32 Bio Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Q32 Bio's estimated annual revenue is currently $7M per year.(i)
  • Q32 Bio's estimated revenue per employee is $183,553

Employee Data

  • Q32 Bio has 38 Employees.(i)
  • Q32 Bio grew their employee count by -12% last year.

Q32 Bio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
FOUNDER AND CHIEF SCIENTIFIC OFFICERReveal Email/Phone
3
Chief Technical OfficerReveal Email/Phone
4
President and Chief Financial OfficerReveal Email/Phone
5
EVP, Corporate Strategy and Program OperationsReveal Email/Phone
6
SVP, Head PeopleReveal Email/Phone
7
Associate Director, AccountingReveal Email/Phone
8
Associate DirectorReveal Email/Phone
9
Senior Director, Finance and SEC ReportingReveal Email/Phone
10
Associate Director ToxicologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M1-50%N/AN/A
#3
$5.1M3322%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M2-60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
N/A1110%N/AN/A
#10
$5.4M290%N/AN/A
Add Company

What Is Q32 Bio?

Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases. Focused on the IL-7 pathway and complement system, Q32 Bio is addressing dysregulation to help patients take back control of their lives in diseases with few to no treatment options, or those diseases where current therapeutics provide inadequate relief.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$7M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M38-12%N/A
#2
$4M380%$10M
#3
$5.5M38-7%N/A
#4
$4.4M38N/AN/A
#5
$4.4M3846%N/A